If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.60    -0.25 (-3.65%)
Bid:
6.20
Ask:
7.00
Spread: 0.80 (12.903%)
Market Cap: £9.89m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director/PDMR Shareholding

2 Jan 2026 16:45

RNS Number : 5352N
Ondo InsurTech PLC
02 January 2026
 

2 January 2026

Ondo InsurTech Plc

("Ondo" or the "Company")

 

Share Incentive Plan Purchase

 

Director/PDMR Shareholding

 

Ondo InsurTech Plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, received notification on 30 December 2025 from Fiduchi Trustees Limited (UK) (the "SIP Trustee") in relation to the purchase of ,14,919 Ondo ordinary shares of 5p each ("Ordinary Shares") for the benefit of participants of the Ondo Share Incentive Plan (the "SIP"), which includes Craig Foster and Kevin Withington, both Directors of the Company, outlined below in accordance with the rules of the SIP (the "SIP Award").

 

The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which each participating employee will acquire Ordinary Shares at the prevailing market price per share using contributions deducted from pre-tax salary in each calendar month ("Partnership Shares"), with each participating employee being awarded one Ordinary Share for each Partnership Share ("Matching Shares") also acquired by the SIP.

 

Details of the number of Partnership Shares purchased by each of the Directors at a price of 22.0 pence per Ordinary Share, and the number of Matching Shares allocated by the SIP Trustee to the participants for no consideration, is set out against their names in the table below.

 

Name

Title

Number of Partnership Shares

Number of Matching Shares

Total resulting beneficial holding

Percentage resulting beneficial holding

Craig Foster(1)

Chief Executive Officer

681

681

2,499,614

1.67%

Kevin Withington

Chief Financial Officer

681

681

347,686

0.23%

 

(1) 270,000 Ordinary Shares are held by Craig Foster's wife

 

 

Enquiries

 

For further information, please visit www.ondoplc.com or contact the following:

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Daniel Ingram

Amber Philipps

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a) 

Name 

 

Craig Foster

2

 

Reason for the notification

 

a)

 

Position/status 

 

Chief Executive Officer and PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Ondo InsurTech Plc

b)

 

LEI

 

2138005Y5QBJQMOOI719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

ISIN: GB00BNVVGD77 

b)

 

Nature of the transaction

 

 

Purchase and allocation of Partnership and Matching Shares (no consideration), respectively, under the Ondo SIP.

c)

 

Price(s) and volume(s)

 

 

Prices

 

Volumes

22.00p

nil

681

681

 

 

d)

 

Aggregated information

 

 

 

Prices

 

Aggregated volume

11.00p

1,362

 

e)

 

Date of the transaction

 

29 December 2025

f)

 

Place of the transaction

 

London Stock Exchange, Main Market (XLON)

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a) 

Name 

 

Kevin Withington

2

 

Reason for the notification

 

a)

 

Position/status 

 

Chief Financial Officer and PDMR

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Ondo InsurTech Plc

b)

 

LEI

 

2138005Y5QBJQMOOI719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

ISIN: GB00BNVVGD77 

b)

 

Nature of the transaction

 

 

Purchase and allocation of Partnership and Matching Shares (no consideration), respectively, under the Ondo SIP.

c)

 

Price(s) and volume(s)

 

 

Prices

 

Volumes

22.00p

Nil

681

681

 

 

d)

 

Aggregated information

 

 

 

Prices

 

Aggregated volume

11.00p

1,362

 

e)

 

Date of the transaction

 

29 December 2025

f)

 

Place of the transaction

 

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVRLTIFIIR
Date   Source Headline
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review
1st Aug 20258:56 amRNSTotal Voting Rights
30th Jul 20257:30 amRNSWarrant Exercise
30th Jul 20257:00 amRNSAnnual Financial Report
28th Jul 20251:44 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNS-RLeakBot Partnership with vipHomeLink in the U.S.
7th Jul 20251:00 pmRNSNotice of Results
1st Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 20257:30 amRNSTotal Voting Rights
30th Jun 20257:05 amRNSDirector/PDMR Shareholding
26th Jun 202512:30 pmRNSDirector/PDMR Shareholding
19th Jun 20254:01 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSBear River Mutual to Pilot LeakBot in the US
12th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 202510:01 amRNSDirector/PDMR Shareholding
6th May 202512:34 pmRNSHolding(s) in Company
1st May 202510:00 amRNSDirector/PDMR Shareholding
1st May 202510:00 amRNSTotal Voting Rights
15th Apr 20255:06 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
11th Apr 20257:00 amRNSThe Hanover to pilot LeakBot in the United States
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSTotal Voting Rights
11th Mar 20254:56 pmRNSDirector/PDMR Share Dealing
4th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNS-RMutual of Enumclaw to Expand LeakBot Program
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNS-RPURE expands LeakBot program
13th Feb 20257:00 amRNSTrading Update
13th Feb 20257:00 amRNSLiberty Mutual Insurance to Pilot LeakBot in US
5th Feb 202511:54 amRNSWarrant Exercise and Director/PDMR Shareholding
3rd Feb 20252:02 pmRNSDirector/PDMR Shareholding and TVR - Replacement
3rd Feb 20257:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
3rd Feb 20257:00 amRNSBlock listing Interim Review
31st Jan 20257:00 amRNS-RNorthumbrian Water to trial LeakBot
20th Jan 20253:40 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20245:58 pmRNSBlock Listing Application - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.